Pharmaceutical drug opportunity assessment
Our insights and recommendations will give you the confidence to make the right strategic decisions at the early stages of commercialisation
Product development is the lifeblood of the pharmaceutical industry. But evaluating the wealth of potential opportunities at the early stages of drug discovery and commercialisation is fraught with uncertainty. We can help you to assess and evaluate opportunities systematically and comprehensively, using a range of qualitative research and quantitative research methods to answer questions such as:
- Where are the unmet needs in the marketplace?
- What is the viability of this product concept?
- What is the size of the market opportunity?
- What is the likely demand for this product?
- Where are the growth markets?
- What is the competitive landscape?
- What should our portfolio look like?
Custom research offerings include:
- Market access consulting
- Demand assessments and forecasting
- Concept evaluations
- Market and product analysis
- Portfolio planning
- Competitor analysis
- Using demand assessment techniques to evaluate the market landscape and product opportunity
The challenge:Our client wanted to evaluate the potential of two treatments which would offer efficacy and side effects similar to those of biologics in atopic dermatitis. Therefore our client needed to understand more about the US and German market landscape in moderate-severe atopic dermatitis and how these advanced treatments might fit into the treatment algorithim when they are launched, as well as the potential drivers…read more »How the opportunity for a product treating a rare haematology disease in Emerging Markets was evaluated using a multi-stakeholder approach
Our client wanted to determine how to maximise the commercial opportunities for a product indicated for a rare disease in a range of emerging marketsread more »How a trade-off technique identified unmet needs for surgery equipment
Our client, a manufacturer of surgical equipment, had identified an area in the operating room where they wished to expand their product range, and wanted to determine if there was sufficient unmet need in this area to justify the investment in developing a new product range.read more »
- Some example case studiesHow Paediatricians and GPs revealed key insights to help develop a science story for a child nutritional supplement
The challenge:Our client needed to develop a science story in order to increase uptake for their child nutritional supplement. Research was required in order to define the patient target, frame the challenge of growth delays to be an effective call to action, articulate objectives for the product and the best way to express its value proposition. The solution:We conducted a mix of “workshop-style” focus groups…read more »How we helped our client to understand the opportunities across Asia and other emerging markets using interactive outputs
The challenge:Our client needed to understand why the use of statins in type 2 diabetes patients in South Korea, China, Thailand and other developing countries is low / sub-optimal. Research was required to understand the diabetic patient journey in order to assess the opportunities to expand HCP knowledge on the importance of lipid lowering for type 2 diabetes patients. The client also wanted to explore…read more »How we used a hybrid qual-quant methodology to assess the market opportunity for a new rare disease treatment
The challenge: Our client is a recently established independent biopharmaceutical company specialising in small molecule development. They were developing a new oral compound for the treatment of a rare genetic disease for which the standard treatment is administered intravenously, however a large proportion of patients receive monitoring only or remain undiagnosed. Their objective was to successfully launch their product in order to provide clinically meaningful…read more »